{
    "2019-01-03": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Why Johnson & Johnson Stock is Clearly Set to Rise Again",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Stock",
                        "Rise"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "VIVUS (VVUS) Banks on New Drug Pancreaze, Qsymia Lacks Luster",
                "features": {
                    "keywords": [
                        "VIVUS",
                        "Pancreaze",
                        "Qsymia"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Johnson & Johnson (JNJ) Stock Moves -1.59%: What You Should Know",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Stock",
                        "-1.59%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Buy Apple Stock Once It Hits This Level",
                "features": {
                    "keywords": [
                        "Apple",
                        "Stock",
                        "Buy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Triangle pharma inks deal with Johnson and Johnson that's potentially worth $818M",
                "features": {
                    "keywords": [
                        "Triangle pharma",
                        "Johnson and Johnson",
                        "$818M"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Can the nose point the way to early lung cancer detection? This Peninsula company's Big Pharma deal aims to find out",
                "features": {
                    "keywords": [
                        "nose",
                        "lung cancer",
                        "Big Pharma"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-01-03",
                "original_text": "Health Care Sector Update for 01/03/2019: CELG, BMY, KTOV, OHRP, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "CELG",
                        "BMY",
                        "JNJ"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-04",
                "original_text": "Stocks making the biggest moves premarket: AAPL, CELG, JNJ, UBS & more",
                "features": {
                    "keywords": [
                        "Stocks",
                        "AAPL",
                        "CELG",
                        "JNJ"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-05",
                "original_text": "Dow set to sink | Apple plunges 9% | Celgene surges on buyout offer",
                "features": {
                    "keywords": [
                        "Dow",
                        "Apple",
                        "Celgene",
                        "buyout"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-06",
                "original_text": "U.S. drugmaker J&J's India sales dip 3 percent in 2017/18: filing",
                "features": {
                    "keywords": [
                        "U.S.",
                        "drugmaker",
                        "J&J",
                        "India",
                        "sales",
                        "dip"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-01-07",
                "original_text": "U.S. drugmaker Johnson & Johnson's India sales dip 3 percent in 2017/18 - filing",
                "features": {
                    "keywords": [
                        "U.S.",
                        "drugmaker",
                        "Johnson & Johnson",
                        "India",
                        "sales",
                        "dip"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}